CENCORA, INC. Equity Securities, FV-NI, Unrealized Gain (Loss)
CENCORA, INC. (COR) reported Equity Securities, FV-NI, Unrealized Gain (Loss) of $10.50 million for the 3-month period ending 2025-12-31, per its 10-Q filed 2026-02-04.
Financial Statements › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiUnrealizedGainLoss · last filed 2026-08-05
- CENCORA, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-12-31 was $10.50M.
- CENCORA, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-09-30 was -$16.50M.
- CENCORA, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2025-06-30 was $27.30M, a 105.26% increase year-over-year.
- CENCORA, INC. equity securities, fv-ni, unrealized gain (loss) for the quarter ending 2024-06-30 was $13.30M.
| Period end | Equity Securities, FV-NI, Unrealized Gain (Loss) 3 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 6 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 9 month | Equity Securities, FV-NI, Unrealized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2025-12-31 | $10.50M 10-Q · filed 2026-02-04 | -$6.00M derived: sum of 2 quarters · filed 2026-02-10 | $21.30M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-09-30 | -$16.50M derived: 8-K 12 month − 10-Q 9 month · filed 2026-02-10 | $10.80M derived: sum of 2 quarters · filed 2026-08-05 | $14.10M 8-K · filed 2026-02-10 | |
| 2025-06-30 | $27.30M 10-Q · filed 2026-08-05 | $30.60M 10-Q · filed 2026-08-05 | ||
| 2024-06-30 | $13.30M 10-Q · filed 2025-08-06 | -$24.80M 10-Q · filed 2025-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |